Results 11 to 20 of about 19,142 (214)

Exploring the mechanisms underlying stroke volume variability reduction in a murine model of heart failure with reduced ejection fraction.

PLoS ONE, 2023
Heart failure with reduced ejection fraction (HFrEF) is accompanied by disregulation of cardiovascular function. Heart rate variability (HRV) is commonly used to assess autonomic dysfunction in HFrEF.
Gemma Fernández-Mendoza, Abraham Méndez-Fernández, Hugo J Alves-Figueiredo, Gerardo García-Rivas, Moisés Santillán   +4 more
doaj   +1 more source

Benefits of combination pharmacotherapy for HFrEF [PDF]

Nature Reviews Cardiology, 2020
In a new cross-trial analysis of patients with heart failure with reduced ejection fraction, researchers predict that a comprehensive strategy combining several pharmacological approaches reduces hospitalization and mortality compared with conventional therapy.
openaire   +2 more sources

Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking

Cardiovascular Diabetology, 2022
Background Heart failure with reduced ejection fraction (HFrEF) is a major health burden worldwide with high morbidity and mortality. Comorbidities of HFrEF complicate treatment and lead to poor prognosis, among which hypertension (HTN) and diabetes ...
Ge Zhang, Ke Shi, Wei-Feng Yan, Xue-Ming Li, Yuan Li, Ying-Kun Guo, Zhi-Gang Yang   +6 more
doaj   +1 more source

Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction

Scientific Reports, 2022
The performance and clinical implications of the deep learning aided algorithm using electrocardiogram of heart failure (HF) with reduced ejection fraction (DeepECG-HFrEF) were evaluated in patients with acute HF.
JungMin Choi, Sungjae Lee, Mineok Chang, Yeha Lee, Gyu Chul Oh, Hae-Young Lee   +5 more
doaj   +1 more source

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction

Open Medicine, 2020
A model for predicting the prognosis of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) is currently not available. This study aimed to develop an age-biomarker-clinical history prognostic index (ABC-PI) and validate ...
Li Hao, Cui Yuan, Tian Jin, Yang Hong, Zhang Qing, Wang Ke, Han Qinghua, Zhang Yanbo   +7 more
doaj   +1 more source

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention

Frontiers in Cardiovascular Medicine, 2022
BackgroundChronic kidney disease (CKD) is very common in patients who are at a high risk of developing incident heart failure with reduced ejection fraction (HFrEF).
Wenguang Lai, Wenguang Lai, Wenguang Lai, Xiaoli Zhao, Sijia Yu, Sijia Yu, Sijia Yu, Ziling Mai, Ziling Mai, Ziling Mai, Yang Zhou, Yang Zhou, Zhidong Huang, Zhidong Huang, Qiang Li, Qiang Li, Haozhang Huang, Haozhang Huang, Haozhang Huang, Huanqiang Li, Huanqiang Li, Haiyan Wei, Dachuan Guo, Yun Xie, Yun Xie, Yun Xie, Shanggang Li, Shanggang Li, Hongyu Lu, Hongyu Lu, Jin Liu, Jin Liu, Shiqun Chen, Shiqun Chen, Yong Liu, Yong Liu, Yong Liu   +36 more
doaj   +1 more source

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes

ESC Heart Failure, 2023
Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF] 
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda   +11 more
doaj   +1 more source

Consequences of group III/IV afferent feedback and respiratory muscle work on exercise tolerance in heart failure with reduced ejection fraction

Experimental Physiology, 2023
Exercise intolerance and exertional dyspnoea are the cardinal symptoms of heart failure with reduced ejection fraction (HFrEF). In HFrEF, abnormal autonomic and cardiopulmonary responses arising from locomotor muscle group III/IV afferent feedback is one
Joshua R. Smith, Jonathon W. Senefeld, Kathryn F. Larson, Michael J. Joyner   +3 more
doaj   +1 more source

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis

Brazilian Journal of Medical and Biological Research
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%).
Chao Ma, Huan Luo, Lei Fan, Xiaoyan Liu, Chengshan Gao   +4 more
doaj   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source